KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $314,000 | -10.3% | 30,807 | -7.5% | 0.00% | 0.0% |
| Q1 2021 | $350,000 | -34.2% | 33,299 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $532,000 | +3.3% | 34,705 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | -25.5% | 35,383 | -3.1% | 0.00% | -50.0% |
| Q2 2020 | $691,000 | -36.3% | 36,531 | -35.4% | 0.00% | -50.0% |
| Q1 2020 | $1,084,000 | +18.0% | 56,546 | +17.9% | 0.00% | +33.3% |
| Q4 2019 | $919,000 | +447.0% | 47,972 | +174.4% | 0.00% | – |
| Q3 2019 | $168,000 | – | 17,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |